Skip to main content
. 2020 Jan 8;4(1):bjgpopen20X101001. doi: 10.3399/bjgpopen20X101001

Table 1. Participant, healthcare, and disease characteristics.

Survey participants(n = 127)a Interview participants(n = 26)a
Age, years
Median (range) 71 (44–96) 69.5 (55–88)
 <60 12 (9.4b) 3 (11.5)
 60–74 78 (61.4b) 12 (46.2)
 ≥75 37 (29.1b) 11 (42.3)
Sex
 Male 102 (80.3) 18 (69.2)
Female 25 (19.7) 8 (30.8)
Cancer type
 Oesophagealc 102 (80.3) 15 (57.7)
 Gastricd 25 (19.7) 11 (42.3)
Ethnic group
 White 124 (97.6) 26 (100.0)
Other 3 (2.4) 0 (0.0)
Region
 East 77 (60.6) 13 (50.0)
North East 50 (39.4) 13 (50.0)
Comorbidities
 Arthritis 38 (29.9) 13 (50.0)
 Cancer — other than O/G 22 (17.3) 5 (19.2)
 Heart disease 17 (13.4) 2 (7.7)
 Lung disease 13 (10.2) 2 (7.7)
 Anxiety or depression 13 (10.2) 2 (7.7)
 Barrett’s or reflux disease 10 (7.9) 1 (3.8)
 Any of the above 72 (56.7) 16 (61.5)
OTC medication
 None 79 (62.2) 17 (65.4)
 Antacid or similar 30 (23.6) 7 (26.9)
 Other 8 (6.3) 1 (3.8)
Reported GP consultations
 Nonee 13 (10.2) 6 (23.1b)
 1 56 (44.1) 10 (38.5b)
 2 35 (27.6) 4 (15.4b)
 ≥3 21 (16.5) 6 (23.1b)
Referral route
 Urgentf 88 (69.3) 16 (61.5)
 Routine 19 (15.0) 6 (23.1)
 Other 9 (7.1) 2 (7.7)
Urgent referral based on GP consultations
 Nonee 8 (6.3) 2 (7.7b)
 1 41 (32.3) 8 (30.8b)
 2 24 (18.9) 2 (7.7b)
 ≥3 15 (11.8) 4 (15.4b)
Cancer stage pre-treatment
 I/II 59 (46.5) 12 (46.2)
 III/IV 64 (50.4) 14 (53.8)

aValues are n (%) unless otherwise stated. Missing data not included bPercentages subject to rounding error. cTumours located in the upper or middle or lower oesophagus and gastro-oesophageal junction, including both adenocarcinomas and squamous cell carcinomas. dTumours located in the cardia, fundus, body, antrum, or pylorus. ePatient referred opportunistically, that is, having attended primary care for another reason. fUrgent referral is the 2-week wait suspected cancer pathway.

O/G = oesophageal or gastric. OTC = over the counter.